Author: Sarah Johnson

It’s not too often that pharmaceutical drugs become household names, but that’s happening with medicines in the weight loss market. Brands such as Wegovy and Zepbound — the leading anti-obesity therapies — are now well known and are generating billions of dollars in annual sales. That’s why other drugmakers want to dip their toes in this lucrative and high-growth market. AbbVie (NYSE: ABBV) is one of them. The company, best known for its work in immunology, recently made a move to enter the weight loss space. Does that make AbbVie stock a buy today? Where to invest $1,000 right now?…

Image source: The Motley Fool. MongoDB (NASDAQ: MDB)Q4 2025 Earnings CallMar 05, 2025, 5:00 p.m. ET Contents: Prepared Remarks: Operator Good day, and welcome to MongoDB’s Q4 fiscal year 2025 earnings call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker, Brian Denyeau, from ICR. Please go ahead. Brian Raferty Denyeau — Investor Relations Thank you, Sherry. Good afternoon, and thank you for joining us today to review MongoDB’s fourth…

Image source: The Motley Fool. CrowdStrike (NASDAQ: CRWD)Q4 2025 Earnings CallMar 04, 2025, 5:00 p.m. ET Contents: Prepared Remarks: Operator Hello, and welcome to CrowdStrike’s fourth quarter and fiscal year 2025 financial results conference call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, we will conduct a question-and-answer session. Please be advised that today’s conference is being recorded. I would now like to hand the call over to Maria Riley, vice president of investor relations. Maria, please go ahead. Maria Riley — Vice President, Investor Relations Good afternoon, and thank you for your participation…